Foschini Medical Aid

Administrator: Discovery Health

The correct Foschini procedure and consult option terminated on the 31st of December 2011 is as follows:
SCHEME/PLAN/OPTION NAME: FOSCHINI HL PROCEDURE & CONSULT
SUBMITTING OPTION: FHLPC 688315
STALE CLAIM PERIOD: 120 Days for claims prior to 2012

**** SUPERCEDES THE FOLLOWING PUBLISHED DECEMBER 2011 ****

 

Dispensing as well as Procedure and Consultation claims for TFG Medical Aid Scheme, formerly known as the Foschini Medical

Aid Scheme should be submitted on the existing Discovery Health option (DSGHL 604944) and the options listed in the table

below will be terminated on 31 December 2011.

 

SCHEME/PLAN/OPTION NAME SUBMITTING OPTION STALE CLAIM PERIOD

 

FOSCHINI ACUTE FSGDA 641475

120 days for claims prior

to 2012

FOSCHINI PLAN A CHRONIC FSGDC 641491

FOSCHINI P&C FHLPC 641432

 

Medinol – Medical Aid Claims Software

 

Incoming search terms:



*********************************************************

About Medinol:
Medinol is one of the few purpose-built practice management application to meet the unique needs of independent private healthcare providers. Today Medinol helps over 130 providers throughout South Africa run more efficient and profitable practices, while delivering outstanding patient care. As an on-premise software, Medinol and the data it manages, is fully under your control. This enhances your independence and privacy: what happens in your rooms, stays in your rooms. Medinol helps manage your patient information, generates your billings, submits your claims, control your outstandings, and get your accounts paid quickly. Medinol has been in operation since 1984 demonstrating its proven efficacy. Medinol’s mission is to help independent practices succeed in an ever-changing healthcare environment. More information can be found at http://medinol.co.za.

Contact:
Fudley Bezuidenhout Pr.Eng.
Founder and CEO
Email: info@medinol.co.za
Ph: 021-906-2296
Cell: 082-688-9610

*********************************************************

Leave a Reply

Your email address will not be published. Required fields are marked *